You have 9 free searches left this month | for more free features.

Diffuse%20large%20B-cell%20lymphoma

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Disease Trial in Cairo (L-Glutamine, Oral Powder for Reconstitution, Standard of care)

Recruiting
  • Sickle Cell Disease
  • L-Glutamine, Oral Powder for Reconstitution
  • Standard of care
  • Cairo, Non-US, Egypt
  • +1 more
May 7, 2022

Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])

Completed
  • Bronchiolitis Obliterans
  • Graft Vs Host Disease
  • Pirfenidone 267 MG [Esbriet]
  • Palo Alto, California
    Stanford University School of Medicine
Jun 8, 2022

Tumors Trial in Worldwide (5-FU, Docetaxel, Enzalutamide)

Completed
  • Neoplasms
  • San Francisco, California
  • +10 more
Jan 6, 2022

Mass Spectral Fingerprinting in Lung Cancer

Recruiting
  • Lung Cancer
  • No intervention
  • Zurich, ZH, Switzerland
    University Hospital Zurich, Division of Pneumology
Jan 13, 2022

Obstructive Sleep Apnea Trial in Sao Paulo (Continuous Positive Airway Pressure)

Recruiting
  • Obstructive Sleep Apnea
  • Continuous Positive Airway Pressure
  • Sao Paulo, Brazil
    Sleep Laboratory, Heart Institute, Pulmonary Division, Hospital
Feb 14, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Cytomegalovirus Infection Trial in United States (Brincidofovir, Placebo)

Completed
  • Cytomegalovirus Infection
  • Birmingham, Alabama
  • +25 more
Jun 28, 2021

Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)

Active, not recruiting
  • Hodgkin Lymphoma
  • +6 more
  • Intravenous (IV) and oral Vitamin C
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022

Heart Failure With Preserved Ejection Fraction (HFpEF) Trial in Netherlands (ILR implantation)

Completed
  • Heart Failure With Preserved Ejection Fraction (HFpEF)
  • ILR implantation
  • Enschede, Netherlands
  • +4 more
May 19, 2022

Camrelizumab in Treatment of Advanced Non-squamous

Recruiting
  • Lung Cancer
  • Nantong, Jiangsu, China
    Department of Pharmacy, Affiliated Hospital of Nantong Universit
May 19, 2022

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Immune Mediated Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Cancer
  • Little Rock, Arkansas
  • +51 more
Jun 8, 2022

Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Web Application
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Myocardial Infarction, Anemia Trial in Worldwide (Red Blood Cell Transfusion)

Recruiting
  • Myocardial Infarction
  • Anemia
  • Red Blood Cell Transfusion
  • Little Rock, Arkansas
  • +131 more
May 3, 2022

Plasma Cell Myeloma Trial in United States (Isatuximab SAR650984, Pomalidomide, Dexamethasone)

Completed
  • Plasma Cell Myeloma
  • Isatuximab SAR650984
  • +2 more
  • Scottsdale, Arizona
  • +12 more
Jul 8, 2021

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • Wuhan, Hu Bei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022

Whiplash, Temporomandibular Joint Pain, Dry Needling Technique Trial in Madrid (Dry needling)

Not yet recruiting
  • Whiplash
  • +2 more
  • Dry needling
  • Madrid, Spain
    Patricia Recio Ramos
Aug 28, 2023

Healthy Trial in Berlin (Tralokinumab administered as 1 × X mL with Device A, Tralokinumab administered as 2 × Y mL with Device

Completed
  • Healthy
  • Tralokinumab administered as 1 × X mL with Device A
  • Tralokinumab administered as 2 × Y mL with Device B
  • Berlin, Germany
    LEO Pharma Investigational Site
Jan 4, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Increase Success Rate of Tooth Transplantation Trial in Leuven (stereolithography tooth replica)

Completed
  • Increase Success Rate of Tooth Transplantation
  • stereolithography tooth replica
  • Leuven, Belgium
    KULeuven
Nov 15, 2021

Cognitive Decline, Blood Pressure, Hypertension Trial in Dallas (Clinical Support Decision Tool)

Recruiting
  • Cognitive Decline
  • +2 more
  • Clinical Support Decision Tool
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 29, 2022

Gout, Chronic Kidney Diseases Trial in Southend on Sea (Anakinra 100mg and Placebo Depo-Medrone, Depo-Medrone 120mg and Placebo

Completed
  • Gout
  • Chronic Kidney Diseases
  • Anakinra 100mg and Placebo Depo-Medrone
  • Depo-Medrone 120mg and Placebo (Anakinra)
  • Southend on Sea, Essex, United Kingdom
    Southend Hospital
Apr 5, 2022

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (recombinant anti-PD-L1 mAb injection combined with carboplatin and

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 9, 2022

Myeloma Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Myeloma
  • Hyperbaric oxygen
  • Rochester, New York
    James P. Wilmot Cancer Center at University of Rochester Medical
May 5, 2022

Celiac Disease Trial in Boston (Gluten powder 4g)

Completed
  • Celiac Disease
  • Gluten powder 4g
  • Boston, Massachusetts
  • +1 more
May 5, 2022